Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus

Background Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in patients with chronic or resolved HBV infection undergoing anticancer therapy. There is a risk of HBV reactivation after infusion of chimeric antigen receptor (CAR) T cells for patients with refractory/...

Full description

Bibliographic Details
Main Authors: Jian Zhou, Lu Han, Keshu Zhou, Baijun Fang, Linlin Li, Quanli Gao, Hu Zhou, Yongping Song, Qingsong Yin, Xinghu Zhu, Lingdi Zhao, Xudong Wei, Bengling Xu, Jishuai Zhang
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e000927.full

Internet

https://jitc.bmj.com/content/8/2/e000927.full

Similar Items